Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
By A. Cleare, C. Pariante, A. H. Young, I. Anderson, D. Christmas, P. Cowen, C. Dickens, I. Ferrier, John R. Geddes, S. Gilbody and 9 more. Journal of Psychopharmacology, 2015
679 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health, Social Psychology
View Paper: https://www.semanticscholar.org/paper/3f309c020ffa35ab86897251057c0ff7e9cf105d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Social Psychology
Citations in the corpus
- Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology (2009, neutral): “Discontinuation of an antidepressant should follow recommendations in related BAP guidelines and taper over 4 weeks if possible (Cleare et al., 2015).”
- Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis (2016, background): “The major therapeutic agents for treating depression are antidepressants, mostly selective serotonin reuptake inhibitors or combined serotonin/noradrenaline reuptake inhibitors [16].”
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “…(e.g. from books, book chapters and government reports) and from existing depression and bipolar disorder guidelines (Bauer et al., 2002a, 2002b; Cleare et al., 2015; Ellis, 2004; Goodwin, 2009; Grunze et al., 2002, 2003, 2004, 2013; Malhi et al., 2009a, 2009b; NICE, 2006, 2009; RANZCP, 2004;…”
- Depression and Anxiety (2008, neutral): “Adapted from Cleare A, Pariante CM, Young AH, et al.(11)”